Nova Eye (Australia) Insiders
| EYE Stock | 0.10 0.01 9.09% |
Nova Eye employs about 14 people. The company is managed by 14 executives with a total tenure of roughly 33 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Nova Eye's management performance can provide insight into the firm performance.
| BEng BE Chairman Founder Chairman |
| Victor Previn Chairman Founder Chairman |
Nova |
Nova Eye Management Team Effectiveness
The company has return on total asset (ROA) of (0.2193) % which means that it has lost $0.2193 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4977) %, meaning that it generated substantial loss on money invested by shareholders. Nova Eye's management efficiency ratios could be used to measure how well Nova Eye manages its routine affairs as well as how well it operates its assets and liabilities.Nova Eye Workforce Comparison
Nova Eye Medical is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,859. Nova Eye maintains roughly 14.0 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.42. Nova Eye Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Nova Eye Medical Price Series Summation is a cross summation of Nova Eye price series and its benchmark/peer.
Nova Eye Notable Stakeholders
A Nova Eye stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nova Eye often face trade-offs trying to please all of them. Nova Eye's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nova Eye's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BEng BE | Founder Chairman | Profile | |
| Victor Previn | Founder Chairman | Profile | |
| Joaquin Wolff | President iTrack | Profile | |
| BSc AM | MD Director | Profile | |
| BSc FAICD | Advisor Board | Profile | |
| Keith Byrne | Vice Operations | Profile | |
| BEc CA | Company Secretary | Profile | |
| Bill Swaim | Pres Ellex | Profile | |
| Mark Flynn | Investor Relations | Profile | |
| Liam Cook | Chief Officer | Profile | |
| Kate Hunt | Head Marketing | Profile | |
| David MD | Chief Officer | Profile | |
| Kimberley Menzies | Group Manager | Profile | |
| Don Watton | Vice Service | Profile |
About Nova Eye Management Performance
The success or failure of an entity such as Nova Eye Medical often depends on how effective the management is. Nova Eye management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nova management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nova management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Nova Eye's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nova Eye Medical. Check Nova Eye's Beneish M Score to see the likelihood of Nova Eye's management manipulating its earnings.
Nova Eye Workforce Analysis
Traditionally, organizations such as Nova Eye use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nova Eye within its industry.Nova Eye Manpower Efficiency
Return on Nova Eye Manpower
| Revenue Per Employee | 1.7M | |
| Revenue Per Executive | 1.7M | |
| Net Loss Per Employee | 627.9K | |
| Net Loss Per Executive | 627.9K | |
| Working Capital Per Employee | 647.6K | |
| Working Capital Per Executive | 647.6K |
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.